Afshar-Oromieh, A., Sattler, L. P., Mier, W., Hadaschik, B., Debus, J., & Haberkorn, U. (2017). The clinical impact of additional late PET/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer. Journal of nuclear medicine, 58(5), . https://doi.org/10.2967/jnumed.116.183483
Chicago-Zitierstil (17. Ausg.)Afshar-Oromieh, Ali, Lars Peter Sattler, Walter Mier, Boris Hadaschik, Jürgen Debus, und Uwe Haberkorn. "The Clinical Impact of Additional Late PET/CT Imaging with 68Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer." Journal of Nuclear Medicine 58, no. 5 (2017). https://doi.org/10.2967/jnumed.116.183483.
MLA-Zitierstil (9. Ausg.)Afshar-Oromieh, Ali, et al. "The Clinical Impact of Additional Late PET/CT Imaging with 68Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer." Journal of Nuclear Medicine, vol. 58, no. 5, 2017, https://doi.org/10.2967/jnumed.116.183483.